BIOLOGICALLY ACTIVE PLANT PROTEOGLYCAN AND METHOD OF ITS PREPARING Russian patent published in 2000 - IPC

Abstract RU 2151600 C1

FIELD: medicine, pharmacology, veterinary science, biology. SUBSTANCE: proteoglycan is prepared by disintegration of mitotic plant cells, for example, Solanum tuberosum seedlings (Solanaceae family). Proteoglycan is extracted from aqueous solution, fractionated according with its molecular mass and concentrated to obtain dried matter. The latter has molecular mass (8.0 x 105)-(2.5 x 106) Da and the following elemental composition, wt.-%: nitrogen, 1.12-2.48; hydrogen, 5.15-7.21; carbon, 39.93-44.42 and ash component containing polysaccharide chain, the balance. The latter consists of the following components, wt. -%: neutral sugar residues, 34.0-85.3; glucose, 26.4-33.1; galacturonic acid, 19.0-25.1; arabinose, 1.7-4.4; uronic acids, 12.0-18.0; rhamnose, 1.2-10.0; xylose, 0.1-3.0; mannose, 0.1-5.0; galactose, 2.5-27.0; and protein is up to 15%. Protein consists of amino acid residues in the following amount, ng/0.1 mg of proteo- -glycan: asparagine, 126.0-146.0; serine, 139.0-159.0; glutamine, 263,0-283.0; glycine, 117.0-131.0; alanine, 80.0-100.0; valine, 76.0-96.0; leucine, 85.0-105.0; lysine, 65.0-85.0; arginine, 42.0-62.0; and trace amount of cysteine, isoleucine, histidine, phenylalanine, tyrosine and threonine. Proteoglycan exhibits the following maximal peaks of IR- -spectrum (KBr tablet): 3350, 2920, 1720, 1655, 1620, 1610, 1560, 1510, 1405, 1378, 1296, 1145, 1080, 1040, 920, 842 and 763 cm-1. Proteoglycan is prepared by milling the raw up to paste-like state, extracted with boiling water at the ratio water : material = (1:1)-(1: 2) and kept at 20 C for 23-25 h. Liquid phase is separated by filtration and subjected for fractionation by gel-chromatography or gel-filtration to remove fractions of molecular mass less than 8.0 x 105 Da. Obtained extract is concentrated until dry. EFFECT: broad spectrum of anti-infectious activity of product, absence of adverse effects. 3 cl, 3 tbl, 5 ex

Similar patents RU2151600C1

Title Year Author Number
POLYSACCHARIDE GAMMA-PLANT (γ-PL) SHOWING ANTIINFECTION ACTION WITHOUT HEMAGGLUTINATING EFFECT 1991
  • Chekanovskaja Ljudmila Aleksandrovna
RU2028303C1
COMPOSITION WITH ANTI-INFECTIOUS ACTIVITY 2012
  • Sinitsa Aleksandr Vladimirovich
RU2476205C1
METHOD OF PREPARING SUBSTANCE SHOWING IMMUNOSTIMULATING, ANTIVIRAL AND ANTIBACTERIAL ACTIVITY, SUBSTANCE OBTAINED BY THIS METHOD AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 2001
  • Ataullakhanov R.I.
  • Pichugin A.V.
  • Khaitov R.M.
RU2195308C1
NEW VEGETABLE GLUCAN AS IMMUNOADJUVANT 2004
  • Chekanovskaja Ljudmila Aleksandrovna
RU2331433C2
METHOD FOR PROTECTION AGAINST CORONAVIRUS INFECTION 2020
  • Abidov Musa Tazhudinovich
  • Abidova Alina Musaevna
  • Stepanov Aleksandr Valentinovich
  • Karyaev Aleksandr Georgievich
RU2747467C1
DRUG FOR RESPIRATORY INFECTIOUS DISEASES GLUCAFERON 2011
  • Konusova Valentina Georgievna
  • Vorobejchikov Evgenij Vladimirovich
  • Simbirtsev Andrej Semenovich
  • Shamtsjan Mark Markovich
  • Gavrilov Vladimir Evgen'Evich
RU2450812C1
ROTARY-VANE ICE 2011
  • Gorokhov Vladimir Nikolaevich
RU2496998C2
GANODERMA LUCIDUM STRAIN WHICH IS PROTEOGLYCANE G009 PRODUCER HAVING ANTITUMOR AND IMMUNE-STIMULATING ACTIVITY 1991
  • Kvon Khaeng Li[Kr]
  • Khoon Chung[Kr]
  • Choon Voo Li[Kr]
  • Chun Khe Chung[Kr]
RU2082755C1
NONSPECIFIC IMMUNOTHERAPY AGENT 2007
  • Mkrtchjan Levon Nikitovich
RU2341272C1
AGENT OF ANTIMETASTATIC ACTION 2007
  • Mkrtchjan Levon Nikitovich
RU2341271C1

RU 2 151 600 C1

Authors

Chekanovskaja L.A.

Dates

2000-06-27Published

1999-10-20Filed